Fertility and Infertility Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Clin Biochem. 2010 Oct;43(15):1189-94. doi: 10.1016/j.clinbiochem.2010.07.010. Epub 2010 Jul 23.
The role of angiotensin converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism in early onset coronary artery disease age < 55years (ECAD) is controversial. The aim of this study was to further evaluate the role of this ACE(I/D) gene polymorphism on the risk of premature CAD in patients from western Iran.
The ACE(I/D) genotypes were detected by PCR-RFLP in 323 individuals undergoing their first coronary angiography. Patients were placed into two groups: ECAD and late onset CAD age ≥ 55years (LCAD).
We found a statistically significant association of the ACE D allele, as homozygous or ACE ID plus DD genotypes (ID+DD), only in the ECAD subjects OR=1.35, p=0.015, OR=3.27, p=0.014, and OR=2.8, p=0.013, respectively. In addition, there was a significant association after adjustment for the absence of history of diabetes, presence of normolipidemia and absence of history of blood pressure [OR 1.38, p=0.017 and 2.35, p=0.02]. Our results indicated that the ACE D allele is a risk factor for early onset of CAD even after correcting for conventional risk factors. The incidence of triple vessel disease was significantly higher in individuals carrying ACE(D/D) genotype in ECAD patients compared to those who carried ACE(I/I) genotype (OR 3.38; p=0.019; 57.5% vs. 42.5%; p=0.013).
The presence of D allele of ACE can be important independent risk factor in the onset of CAD patients less than 55 years old in a west population of Iran. Larger collaborative studies are needed to confirm these results.
血管紧张素转换酶(ACE)基因插入/缺失(I/D)多态性在 55 岁以下早发冠状动脉疾病(ECAD)中的作用存在争议。本研究旨在进一步评估该 ACE(I/D)基因多态性在来自伊朗西部的早发冠心病患者中的作用。
通过 PCR-RFLP 在 323 例首次接受冠状动脉造影的患者中检测 ACE(I/D)基因型。患者分为两组:ECAD 和晚发冠心病年龄≥55 岁(LCAD)。
我们发现 ACE D 等位基因,无论是纯合子还是 ACE ID 加 DD 基因型(ID+DD),仅在 ECAD 患者中具有统计学意义的关联,OR=1.35,p=0.015,OR=3.27,p=0.014,OR=2.8,p=0.013。此外,在调整无糖尿病史、血脂正常和无血压病史后,这种关联仍然显著 [OR 1.38,p=0.017 和 2.35,p=0.02]。我们的结果表明,ACE D 等位基因是 CAD 早发的危险因素,即使在纠正传统危险因素后也是如此。与携带 ACE(I/I)基因型的 ECAD 患者相比,携带 ACE(D/D)基因型的个体发生三血管疾病的风险显著更高(OR 3.38;p=0.019;57.5% vs. 42.5%;p=0.013)。
在伊朗西部人群中,ACE 的 D 等位基因的存在可能是 55 岁以下 CAD 患者发病的重要独立危险因素。需要更大规模的合作研究来证实这些结果。